Special MRI for rectal cancer before treatment
Part of Cancer, Digestive system clinical trials.
This trial uses a special MRI technique to help doctors better understand rectal cancer before treatment. It is for people who will receive chemotherapy and radiation before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have rectal adenocarcinoma confirmed by a biopsy.
- You must be scheduled to receive a combination of chemotherapy and radiation before surgery.
- You must be older than 20 years old.
- You must be able to safely have an MRI (no severe claustrophobia or non-removable metal in your body).
- You must not have a serious active infection, heart or lung problem, or severe liver or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using MRI scans to guide radiotherapy can improve treatment for people with a certain type of rectal cancer. It focuses on patients whose tumors have not spread to other parts of the body and who have specific tumor features seen on MRI.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
This trial tests a new way of giving radiation therapy for rectal cancer, using MRI scans to aim the radiation more precisely. It's for people who need chemotherapy and radiation before surgery, and it aims to make treatment more effective while reducing side effects.
This study is testing a special PET/MRI scan to see if it can better guide treatment for stage 2 or 3 rectal cancer. You may qualify if you have locally advanced rectal cancer and are planning to get chemo and radiation before surgery.
This trial tests whether doing an MRI scan of the liver before rectal cancer treatment helps doctors plan care better. You may be asked to have MRI before starting treatment and follow the study plan.
This trial tests whether an MRI scan done during chemoradiation can help doctors track how rectal cancer treatment is working. It may improve how they measure response early so treatment planning can be better tailored.
Hear when a new Neoadjuvant Chemoradiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.